A loss-of-function study demonstrated that knockdown of B-Myb significantly suppressed NSCLC cell growth, cell cycle progression, colony-forming ability, motility, and tumorigenesis in vivo. Here, MYBL2 is linked to non-small cell lung carcinoma.